アトピー性皮膚炎治療の世界市場2019-2029

LINEで送る

1. Executive Summary

1.1. Market Outlook

1.2. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

3. Market Background

3.1. Macro-Economic Factors

3.1.1. Drivers

3.1.2. Restraints

3.1.3. Opportunity Analysis

3.1.4. Trends

4. Market Context

4.1. Global Atopic Dermatitis Treatment Market Size (US$ Mn) and Forecast

4.2. Global Epidemiology of Atopic Dermatitis

4.3. Global Atopic Dermatitis Treatment Market Opportunity Analysis

4.4. Key Regulations and Guidelines

5. Global Atopic Dermatitis Treatment Market (in Value or Size in US$ Mn) Analysis 2014-2018 and Forecast, 2019-2029

5.1. Historical Market Value (US$ Mn) Analysis, 2014-2018

5.2. Current and Future Market Value (US$ Mn) Projections, 2019-2029

5.2.1. Y-o-Y Growth Trend Analysis

5.2.2. Absolute $ Opportunity Analysis

5.2.3. Market Value Comparison

6. Global Atopic Dermatitis Treatment Market Analysis 2014-2018 and Forecast 2019-2029, by Drug Class

6.1. Introduction / Key Findings

6.2. Historical Market Size (US$ Mn) Analysis By Drug Class, 2014-2018

6.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Drug Class, 2019 – 2029

6.3.1. Corticosteroids

6.3.2. Calcineurin Inhibitors

6.3.3. Immunosuppressant

6.3.4. Biologic Therapy

6.3.5. PDE-4 Inhibitor

6.3.6. Antibiotics

6.3.7. Antihistamines

6.3.8. Emollients

6.4. Market Attractiveness Analysis By Drug Class

7. Global Atopic Dermatitis Treatment Market Analysis 2014-2018 and Forecast 2019-2029, by Mode of Administration

7.1. Introduction / Key Findings

7.2. Historical Market Size (US$ Mn) Analysis By Mode of Administration, 2014-2018

7.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Mode of Administration, 2019 – 2029

7.3.1. Topical

7.3.2. Oral

7.3.3. Injectable

7.4. Market Attractiveness Analysis By Mode of Administration

8. Global Atopic Dermatitis Treatment Market Analysis 2014-2018 and Forecast 2019-2029, by Distribution Channel

8.1. Introduction / Key Findings

8.2. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2014-2018

8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Channel, 2019 – 2029

8.3.1. Hospital Pharmacies

8.3.2. Retail Pharmacies

8.3.3. Online Pharmacies

8.3.4. Drug Stores

8.3.5. Mail Order Pharmacies

8.3.6. Dermatology Clinics

8.4. Market Attractiveness Analysis By Distribution Channel

9. Global Atopic Dermatitis Treatment Market Analysis 2014-2018 and Forecast 2019-2029, by Region Type

9.1. Introduction

9.2. Historical Market Size (US$ Mn) Analysis By Region, 2014-2018

9.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2019 – 2029

9.3.1. North America

9.3.2. Latin America

9.3.3. Western Europe

9.3.4. Eastern Europe

9.3.5. Asia-Pacific Excluding Japan

9.3.6. Japan

9.3.7. Middle East and Africa

9.4. Market Attractiveness Analysis By Region

10. North America Atopic Dermatitis Treatment Market Analysis 2014-2018 and Forecast 2019-2029

10.1. Introduction

10.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018

10.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 – 2029

10.3.1. By Country

10.3.1.1. U.S.

10.3.1.2. Canada

10.3.2. By Drug Class

10.3.3. By Mode of Administration

10.3.4. By Distribution Channel

10.4. Market Attractiveness Analysis

10.4.1. By Country

10.4.2. By Drug Class

10.4.3. By Mode of Administration

10.4.4. By Distribution Channel

11. Latin America Atopic Dermatitis Treatment Market Analysis 2014-2018 and Forecast 2019-2029

11.1. Introduction

11.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018

11.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 – 2029

11.3.1. By Country

11.3.1.1. Mexico

11.3.1.2. Brazil

11.3.1.3. Rest of Latin America

11.3.2. By Drug Class

11.3.3. By Mode of Administration

11.3.4. By Distribution Channel

11.4. Market Attractiveness Analysis

11.4.1. By Country

11.4.2. By Drug Class

11.4.3. By Mode of Administration

11.4.4. By Distribution Channel

12. Western Europe Atopic Dermatitis Treatment Market Analysis 2014-2018 and Forecast 2019-2029

12.1. Introduction

12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018

12.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 – 2029

12.3.1. By Country

12.3.1.1. Germany

12.3.1.2. Italy

12.3.1.3. France

12.3.1.4. U.K.

12.3.1.5. Spain

12.3.1.6. BENELUX

12.3.1.7. Nordic

12.3.1.8. Rest of Western Europe

12.3.2. By Drug Class

12.3.3. By Mode of Administration

12.3.4. By Distribution Channel

12.4. Market Attractiveness Analysis

12.4.1. By Country

12.4.2. By Drug Class

12.4.3. By Mode of Administration

12.4.4. By Distribution Channel

13. Eastern Europe Atopic Dermatitis Treatment Market Analysis 2014-2018 and Forecast 2019-2029

13.1. Introduction

13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018

13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 – 2029

13.3.1. By Country

13.3.1.1. Germany

13.3.1.2. Italy

13.3.1.3. France

13.3.1.4. U.K.

13.3.1.5. Spain

13.3.1.6. BENELUX

13.3.1.7. Nordic

13.3.1.8. Rest of Western Europe

13.3.2. By Drug Class

13.3.3. By Mode of Administration

13.3.4. By Distribution Channel

13.4. Market Attractiveness Analysis

13.4.1. By Country

13.4.2. By Drug Class

13.4.3. By Mode of Administration

13.4.4. By Distribution Channel

14. APEJ Atopic Dermatitis Treatment Market Analysis 2014-2018 and Forecast 2019-2029

14.1. Introduction

14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018

14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 – 2029

14.3.1. By Country

14.3.1.1. China

14.3.1.2. India

14.3.1.3. Australia & New Zealand

14.3.1.4. ASEAN

14.3.1.5. Rest of APEJ

14.3.2. By Drug Class

14.3.3. By Mode of Administration

14.3.4. By Distribution Channel

14.4. Market Attractiveness Analysis

14.4.1. By Country

14.4.2. By Drug Class

14.4.3. By Mode of Administration

14.4.4. By Distribution Channel

15. Japan Atopic Dermatitis Treatment Market Analysis 2014-2018 and Forecast 2019-2029

15.1. Introduction

15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018

15.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 – 2029

15.3.1. By Drug Class

15.3.2. By Mode of Administration

15.3.3. By Distribution Channel

15.4. Market Attractiveness Analysis

15.4.1. By Drug Class

15.4.2. By Mode of Administration

15.4.3. By Distribution Channel

16. Middle East and Africa Atopic Dermatitis Treatment Market Analysis 2014-2018 and Forecast 2019-2029

16.1. Introduction

16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018

16.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 – 2029

16.3.1. By Country

16.3.1.1. GCC Countries

16.3.1.2. Northern Africa

16.3.1.3. South Africa

16.3.1.4. Turkey

16.3.1.5. Rest of MEA

16.4. Market Attractiveness Analysis

16.4.1. By Country

16.4.2. By Drug Class

16.4.3. By Mode of Administration

17. Competition Analysis

17.1. Competition Dashboard

17.2. Competition Deep Dive

17.2.1. Sanofi S.A.

17.2.1.1. Overview

17.2.1.2. Product Portfolio

17.2.1.3. Profitability by Market Segments (Product/Mode of Administration/Region)

17.2.1.4. Sales Footprint

17.2.1.5. Strategy Overview

17.2.1.5.1. Marketing Strategy

17.2.1.5.2. Product Strategy

17.2.1.5.3. Mode of Administration Strategy

17.2.2. Galderma S.A

17.2.2.1. Overview

17.2.2.2. Product Portfolio

17.2.2.3. Profitability by Market Segments (Product/Mode of Administration/Region)

17.2.2.4. Sales Footprint

17.2.2.5. Strategy Overview

17.2.2.5.1. Marketing Strategy

17.2.2.5.2. Product Strategy

17.2.2.5.3. Mode of Administration Strategy

17.2.3. Allergan Plc.

17.2.3.1. Overview

17.2.3.2. Product Portfolio

17.2.3.3. Profitability by Market Segments (Product/Mode of Administration/Region)

17.2.3.4. Sales Footprint

17.2.3.5. Strategy Overview

17.2.3.5.1. Marketing Strategy

17.2.3.5.2. Product Strategy

17.2.3.5.3. Mode of Administration Strategy

17.2.4. Novartis AG

17.2.4.1. Overview

17.2.4.2. Product Portfolio

17.2.4.3. Profitability by Market Segments (Product/Mode of Administration/Region)

17.2.4.4. Sales Footprint

17.2.4.5. Strategy Overview

17.2.4.5.1. Marketing Strategy

17.2.4.5.2. Product Strategy

17.2.4.5.3. Mode of Administration Strategy

17.2.5. Bristol-Meyer Squibb

17.2.5.1. Overview

17.2.5.2. Product Portfolio

17.2.5.3. Profitability by Market Segments (Product/Mode of Administration/Region)

17.2.5.4. Sales Footprint

17.2.5.5. Strategy Overview

17.2.5.5.1. Marketing Strategy

17.2.5.5.2. Product Strategy

17.2.5.5.3. Mode of Administration Strategy

17.2.6. Bayer AG

17.2.6.1. Overview

17.2.6.2. Product Portfolio

17.2.6.3. Profitability by Market Segments (Product/Mode of Administration/Region)

17.2.6.4. Sales Footprint

17.2.6.5. Strategy Overview

17.2.6.5.1. Marketing Strategy

17.2.6.5.2. Product Strategy

17.2.6.5.3. Mode of Administration Strategy

17.2.7. Mylan Pharmaceuticals Inc.

17.2.7.1. Overview

17.2.7.2. Product Portfolio

17.2.7.3. Profitability by Market Segments (Product/Mode of Administration/Region)

17.2.7.4. Sales Footprint

17.2.7.5. Strategy Overview

17.2.7.5.1. Marketing Strategy

17.2.7.5.2. Product Strategy

17.2.7.5.3. Mode of Administration Strategy

17.2.8. Astellas Pharma Inc.

17.2.8.1. Overview

17.2.8.2. Product Portfolio

17.2.8.3. Profitability by Market Segments (Product/Mode of Administration/Region)

17.2.8.4. Sales Footprint

17.2.8.5. Strategy Overview

17.2.8.5.1. Marketing Strategy

17.2.8.5.2. Product Strategy

17.2.8.5.3. Mode of Administration Strategy

17.2.9. Anacor Pharmaceuticals, Inc.

17.2.9.1. Overview

17.2.9.2. Product Portfolio

17.2.9.3. Profitability by Market Segments (Product/Mode of Administration/Region)

17.2.9.4. Sales Footprint

17.2.9.5. Strategy Overview

17.2.9.5.1. Marketing Strategy

17.2.9.5.2. Product Strategy

17.2.9.5.3. Mode of Administration Strategy

17.2.10. Regeneron Pharmaceuticals, Inc.

17.2.10.1. Overview

17.2.10.2. Product Portfolio

17.2.10.3. Profitability by Market Segments (Product/Mode of Administration/Region)

17.2.10.4. Sales Footprint

17.2.10.5. Strategy Overview

17.2.10.5.1. Marketing Strategy

17.2.10.5.2. Product Strategy

17.2.10.5.3. Mode of Administration Strategy

17.2.11. Bausch Health Inc.

17.2.11.1. Overview

17.2.11.2. Product Portfolio

17.2.11.3. Profitability by Market Segments (Product/Mode of Administration/Region)

17.2.11.4. Sales Footprint

17.2.11.5. Strategy Overview

17.2.11.5.1. Marketing Strategy

17.2.11.5.2. Product Strategy

17.2.11.5.3. Mode of Administration Strategy

18. Assumptions and Acronyms Used

19. Research Methodology




※当サイトのレポート紹介カバレッジ
■産業:医療、IT、電子、自動車、産業機械、建設、消費財、食品、化学、材料、エネルギー、金融、サービスなど多様
■地域:世界市場、アジア市場、中国市場、欧州市場、北米市場、中南米市場、中東市場、アフリカ市場など全世界
■レポート種類:市場動向、規模、占有率、トレンド、将来展望、未来予測、業界分析、産業分析、企業分析、事業機会分析、戦略提言など多様